Historique
Détail de l'auteur
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à votre sélection Affiner la recherche
ENGLISH : Clinicians' beliefs and awareness of treatment techniques may influence what innovations are perceived as needed and adoption of them. Clinicians at research-affiliated programs, however, may differ from clinicians at programs withou[...]
ENGLISH : Little is known about clinicians' information sources for new treatments or ways to improve dissemination of that information. We analyzed 163 clinicians' responses to a checklist of where and how frequently they obtain information o[...]
C. E. JOHANSON ; C. L. ARFKEN ; S. DI MENZA ; C. R. SCHUSTER | 2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : PériodiqueBACKGROUND: Since 2003, buprenorphine has been approved for the treatment of opioid dependence in office-based practice. Diversion and abuse can be a threat to its continued approval under these conditions. METHODS: As part of a national postm[...]
C. L. ARFKEN ; D. OWENS ; C. MADEJA ; C. DEANGELIS | 2014
Dans Journal of Psychoactive Drugs (Vol.46, n°5, November-December 2014) Article : PériodiqueThe use of synthetic cannabinoids and cathinones in southeastern Michigan was explored using Roger's Diffusion of Innovation theory. A mixed methods approach after specific synthetic cannabinoids and cathinone compounds were scheduled was used t[...]
Women in treatment for substance abuse have been reported to have more severe problems at assessment than men but not to differ in treatment retention. To examine gender differences in problems at assessment, 30-day retention, and treatment comp[...]
FRANÇAIS : Soixante huit consommateurs de cocaïne dépendants d'héroïne sont traités par la buprénorphine et un protocole basé sur le renforcement. En début de traitement, le questionnaire TPQ (Tridimensional Personality Questionnaire) est admi[...]
ENGLISH : The abuse liability of medications is a growing concern as the number of newly approved psychoactive medications increases. Postmarketing surveillance can assist in determining abuse liability, but strategies are not well-defined for[...]
